Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase).

Jill Deacon, Sharif M. Abdelghany, Derek J. Quinn, Daniela Schmid, Julianne Megaw, Ryan F. Donnelly, David S. Jones, Adrien Kissenpfennig, J. Stuart Elborn, Brendan F. Gilmore, Clifford C. Taggart, Christopher J. Scott*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

154 Citations (Scopus)
2062 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase).'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science